Price movement over the last 24 hours
Access Protocol vs Injective — how do they compare? Access Protocol trades at Rp2.25 (market cap Rp117,02M, Rp7,5M 24h volume), while Injective trades at Rp83,895 (market cap Rp8,44T, Rp1,23T 24h volume). The key difference: Injective is far larger — about 72124.4× Access Protocol's market cap, and Access Protocol's circulating supply is 51,5B ACS versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Access Protocol for 15 Days and Injective for 36 Days on average.
| ACS | INJ | |
|---|---|---|
Market Cap | Rp117,02M | Rp8,44T |
Volume (24h) | Rp7,5M | Rp1,23T |
Circulating Supply | 51,5B ACS | 100M INJ |
Typical Hold Time | 15 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Access Protocol (ACS) is trading at Rp2.2603 with a market cap of Rp117.49 million, showing a bearish technical signal overall. The moving averages are strongly bearish, while oscillators are neutral. Key indicators like RSI_6 at 14.50 suggest potential oversold conditions. No recent news is available, and the asset lacks major fundamental updates. The token's hold time is 15 days, indicating short-term trading activity.
The outlook remains cautious due to bearish technicals and low market cap, posing liquidity risks. Opportunities exist if oversold RSI leads to a rebound, but investors should monitor for protocol developments and exchange liquidity. Major risks include high volatility and regulatory uncertainties common in crypto assets.
INJ is trading at Rp83,360 with a market cap of Rp8.39T, showing neutral technical signals overall. The asset is currently positioned between key support at Rp82,799 and resistance at Rp86,949, with mixed moving average signals but neutral oscillators. Recent network activity shows an average hold time of 36 days, indicating moderate holding behavior among investors.
Outlook remains cautiously neutral with potential for movement toward resistance levels. Key opportunities include protocol ecosystem growth, while risks involve typical crypto volatility and regulatory uncertainty. Investors should monitor volume patterns and network adoption metrics for directional cues.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Access Protocol provides a new method for digital media publications and content creators to monetize their work. Instead of traditional subscription payments, users stake the ACS token to gain access to premium digital content.
Read more on ACS →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →